Congleton Jon 4
4 · Mineralys Therapeutics, Inc. · Filed Nov 24, 2025
Insider Transaction Report
Form 4
Congleton Jon
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Stock Option
2025-11-21−24,082→ 0 totalExercise: $0.54Exp: 2031-03-11→ Common Stock (24,082 underlying) - Exercise/Conversion
Common Stock
2025-11-21$0.54/sh+24,082$13,004→ 655,387 total
Footnotes (2)
- [F1]Due to a rounding error, the exercise price for this stock option was originally reported as $0.53 per share on the Reporting Person's Form 3 filed on February 9, 2023.
- [F2]The stock option vested with respect to 25% of the underlying shares on March 12, 2022 and the remaining shares in 36 substantially equal monthly installments thereafter.